Programmed cell death-1 (PD-1) expression has been observed in the leukemic cells of adult patients with AML, with reported frequencies ranging from 42% to 100%, but research on PCD in pediatric AML is limited (10). This evidence concerns the gene PDCD1 and acute myeloid leukemia.